Sponsor & Exhibitor Opportunities

Download the 2010 GLDMDG Meeting Sponsor/Exhibitor Prospectus

Contact:
Anna Talyor
(734) 764-8165
annat@umich.edu


2010 Meeting Sponsors

Major Benefactors

  • Abbott
  • Covance
  • Lilly
  • Pfizer

Gold Sponsors

  • Analytical Bio-Chemistry (ABC) Laboratories
  • MPI Research
  • Seventh Wave

Silver Sponsors

  • Celsis
  • IN/US Systems
  • ThermoFisher
  • Wil Research Laboratories
  • Xenotech

Bronze Sponsors

  • Absorption Systems
  • Arbor Assays
  • Avogadro
  • BD Biosciences
  • Invitrogen
  • PerkinElmer
  • QPS
  • Quotient Bioresearch
4th Annual Meeting Announcement

About the GLDMDG

The purpose of the Great Lakes Drug Metabolism Discussion Group (GLDMDG) is to facilitate interactions among scientists interested in all aspects of drug metabolism and disposition. In its fourth year of existence, the GLDMDG organizes meetings to promote the collegial exchange of ideas on current topics of interest to its members. Learn more...

Stay Connected

Linkedin  Twitter  Facebook

Online Registration Now Closed

Online registration for 5th annual meeting of the Great Lakes Drug Metabolism Discussion Group is now closed. On-site registration will be available on the morning of May 6th.

 


Poster Information

The maximum poster size is 6 ft. wide x 4 ft. tall.

 


Hotel Reservations

The 5th annual meeting of the Great Lakes Drug Metabolism Discussion Group will be held on May 6th and May 7th, 2010 at the Marriott West in St. Louis, Missouri.

Marriot West

You can reserve your room at the discounted rate of $105 per night using Group Code: gldglda at the Marriott West web site.

 


Meeting Program

Thursday, May 6, 2010

Registration, coffee, and poster setup, 10:00 AM

Welcome, 11:00 AM

Multiple Transport Systems in the BBB: Impact on CNS Drug Delivery, 11:10 AM
William F. Elmquist, Professor and Department Head, Department of Pharmaceutics, College of Pharmacy, University of Minnesota

Probing Mechanisms of Inter-Individual Susceptibility to Toxicants with Population-Based Experimental Approaches, 11:50 AM
Ivan Rusyn, Associate Professor, Department of Environmental Sciences and Engineering, University of North Carolina at Chapel Hill

Lunch, poster viewing, and sponsor booths, 12:30 PM

Minimally and Noninvasive Clinical CYP3A Phenotyping, 2:00 PM
Evan Kharasch, Director, Division of Clinical and Translational, Research Professor of Anesthesiology, Washington University at St. Louis

Drug Biotransformation in Children: Role of Ontogeny, Pharmacogenetics and Developmental Context, 2:40 PM
J. Steven Leeder, Professor of Pediatrics and Pharmacology, University of Missouri, Kansas City

Break, 3:20 PM

Drug and Disease Model Based Biologic Drug Development, 3:40 PM
Jenny Chien, Research Advisor, Lilly Research Labs, Eli Lilly & Co.

Quantification of Gemcitabine-DNA Adducts in Patient Blood, a Novel Biomarker, 4:20 PM
Enaksha Wickremsinhe, Principle Research Scientist, Drug Disposition, Eli Lilly

Poster session (author available), sponsor booths, and mixer, 5:00 PM

Dinner, 7:30 PM


Friday, May 7, 2010

Preclinical to Clinical Translation of Tasocitinib (CP-690,550), a JAK Inhibitor, in Rheumatoid Arthritis, 9:00 AM
Martin Dowty, Senior Principal Scientist, Pharmacokinetics Dynamics and Metabolism (PDM), Pfizer

Enabling Compound Progression with Improved Drug-Drug Interaction Predictions, 9:35 AM
Mohamad Shebley, Senior Scientist, Abbott Laboratories

Break, 10:10 AM

Investigation of Metabolism-Mediated Toxicity in Early Development, 10:40 AM
William Humphreys, Bristol-Myers Squibb

Probing the Recognition Signal for Ubiquitination of Suicide-Inactivated Neuronal Nitric Oxide Synthase with a C331A Mutant of the Enzyme, 11:15 AM
Kelly M. Clapp, Graduate Student, University of Michigan

Effects of Valproic Acid on Organic Acid Metabolism in Children: A Metabolic Profiling Study, 11:40 AM
Kristin E. Price, Post-Doc, Children Mercy Hospital

 


2010 Sponsor/Exhibitor Prospectus

The 2010 GLDMDG Meeting Sponsor/Exhibitor Prospectus is now available for download.